Advanced, multimodal brain data collection and analysis
Gathering insightful information on the brain and its disease states.
Research and development within the multiple neuro modalities at the Wyss Center, including devices, biology and radiology, are increasingly generating larger and more complex datasets.
Our team seeks to extract useful information about the brain in health and disease from these datasets, using statistical models, algorithms and machine learning.
The goal is to uncover trends and patterns towards the development of earlier diagnoses and therapies with higher probability of positive clinical outcomes.
Harnessing multi-modal data for systematic development and discovery
Big data is a defining characteristic of neuroscience research and development. Large, integrated datasets from implantable and wearable monitoring devices, radiological imaging, transcriptomics, brain circuit mapping and other biological approaches, provide the unprecedented opportunity to uncover a wealth of insights and predictive patterns that can impact the fields of diagnostics, healthcare management and therapeutics.
Key focus areas in data analysis and software development
- Design and implement computational tools critical to our understanding of large, brain datasets.
- Develop scientific software tools that fit seamlessly into clinical workflows and patient-specific frameworks.
- Create file harmonizing software to allow processing of a wide range of data types and formats.
- Build and implement novel algorithms and real-time (or off-line) data processing software for brain-computer interface applications, long term brain monitoring, forecasting and management of acute events.
- Develop computational tools in line with medical regulatory requirements and effective deployment in clinical settings.
- Derive novel insights into complex clinical disorders such as epilepsy and Parkinson’s disease.
George Kouvas, Wyss Center CTO“An unprecedented quantity, quality and reliability of data is currently being generated by novel neurotechnologies, including the ones we develop at the Wyss Center. This is expected to enable digital biomarker identification and unparalleled insights into disease. Our goal is to use these insights in order to improve diagnostics, therapies and care for patients suffering from neural disorders.”
The Wyss Center announces CE mark for its brain-computer interface software for communication, NeuroKey BCI
NeuroKey BCI enables people who are completely locked-in to communicate in real time.Technology
Shining a light on neurodegenerative disorders
Could a ray of light stop rogue proteins in their tracks and slow the spread of neurodegenerative disease in the brain? EPFL and the Wyss Center are set to find out.Collaboration
Wyss Center joins Wellcome Leap global network dedicated to accelerated breakthroughs in human health
Charter group of 21 world-class institutions representing a network of over 150,000 researchers across six continents sign agreement that sets new bar for fast-paced research and development.Collaboration